{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T13:36:21Z","timestamp":1780320981780,"version":"3.54.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,7]],"date-time":"2022-01-07T00:00:00Z","timestamp":1641513600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.vaccine.2021.12.050","type":"journal-article","created":{"date-parts":[[2022,1,3]],"date-time":"2022-01-03T17:12:54Z","timestamp":1641229974000},"page":"904-911","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Fourteen years of the Pregnancy Registry on maternal immunisation with a reduced-antigen-content tetanus-diphtheria-acellular pertussis (Tdap) vaccine"],"prefix":"10.1016","volume":"40","author":[{"given":"Anastasia","family":"Kuznetsova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Angeles","family":"Ceregido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Jourquin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Campora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda","family":"Tavares-Da-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2021.12.050_b0005","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1093\/ofid\/ofx162.010","article-title":"Epidemiology and trends of pertussis among infants \u2013 United States, 2000\u20132015","volume":"4","author":"Bozio","year":"2017","journal-title":"Open Forum Infectious Diseases"},{"key":"10.1016\/j.vaccine.2021.12.050_b0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6702a1","article-title":"Prevention of pertussis, tetanus, and diphtheria with vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"67","author":"Liang","year":"2018","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.vaccine.2021.12.050_b0015","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1542\/peds.2014-2291","article-title":"First pertussis vaccine dose and prevention of infant mortality","volume":"135","author":"Tiwari","year":"2015","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2021.12.050_b0020","first-page":"1424","volume":"60","author":"Centers for Disease Control and Prevention","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2021.12.050_b0025","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1186\/s12884-017-1559-2","article-title":"Efficacy and safety of pertussis vaccination for pregnant women - a systematic review of randomised controlled trials and observational studies","volume":"17","author":"Furuta","year":"2017","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.vaccine.2021.12.050_b0030","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s12879-020-4824-3","article-title":"Safety and effectiveness of acellular pertussis vaccination during pregnancy: a systematic review","volume":"20","author":"Vygen-Bonnet","year":"2020","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2021.12.050_b0035","first-page":"131","article-title":"Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women\u2013Advisory Committee on Immunization Practices (ACIP), 2012","volume":"62","author":"Centers for Disease Control and Prevention","year":"2013","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2021.12.050_b0040","doi-asserted-by":"crossref","first-page":"77","DOI":"10.15585\/mmwr.mm6903a5","article-title":"Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccines: Updated Recommendations of the Advisory Committee on Immunization Practices \u2014 United States, 2019","volume":"69","author":"Havers","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2021.12.050_b0045","first-page":"433","article-title":"Pertussis vaccines: WHO position paper - September 2015","volume":"90","author":"World Health Organization","year":"2015","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2021.12.050_b0050","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1080\/14760584.2020.1791092","article-title":"A systematic review of the burden of pertussis disease in infants and the effectiveness of maternal immunization against pertussis","volume":"19","author":"Kandeil","year":"2020","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2021.12.050_b0055","doi-asserted-by":"crossref","first-page":"6137","DOI":"10.1016\/j.vaccine.2021.08.074","article-title":"Vaccination programs for pregnant women in Europe, 2021","volume":"39","author":"Maltezou","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.12.050_b0060","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1001\/jama.2014.3633","article-title":"Safety and immunogenicity of tetanus diphtheria and acellular pertussis (Tdap) immunization during pregnancy in mothers and infants: a randomized clinical trial","volume":"311","author":"Munoz","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2021.12.050_b0065","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/j.vaccine.2019.10.105","article-title":"Immunogenicity, transplacental transfer of pertussis antibodies and safety following pertussis immunization during pregnancy: Evidence from a randomized, placebo-controlled trial","volume":"38","author":"Perrett","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.12.050_b0070","doi-asserted-by":"crossref","first-page":"S236","DOI":"10.1093\/cid\/ciw559","article-title":"Sustained effectiveness of the maternal pertussis immunization program in England 3 years following introduction","volume":"63","author":"Amirthalingam","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2021.12.050_b0075","doi-asserted-by":"crossref","first-page":"30545","DOI":"10.2807\/1560-7917.ES.2017.22.22.30545","article-title":"A case-control study to assess the effectiveness of pertussis vaccination during pregnancy on newborns, Valencian community, Spain, 1 March 2015 to 29 February 2016","volume":"22","author":"Bellido-Blasco","year":"2017","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2021.12.050_b0080","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1016\/j.vaccine.2018.02.047","article-title":"Effectiveness of maternal pertussis vaccination in preventing infection and disease in infants: The NSW Public Health Network case-control study","volume":"36","author":"Saul","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.12.050_b0085","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1093\/cid\/cix724","article-title":"Impact of the US maternal tetanus, diphtheria, and acellular pertussis vaccination program on preventing pertussis in infants <2 months of age: A case-control evaluation","volume":"65","author":"Skoff","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2021.12.050_b0090","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/cid\/ciu821","article-title":"A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales, 2012\u20132013","volume":"60","author":"Dabrera","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2021.12.050_b0095","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1016\/j.vaccine.2016.03.049","article-title":"Enhanced surveillance of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccines in pregnancy in the Vaccine Adverse Event Reporting System (VAERS), 2011\u20132015","volume":"34","author":"Moro","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.12.050_b0100","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2015-209909","article-title":"Perinatal management of fetal supraventricular tachycardia complicated by maternal pertussis","volume":"2015","author":"Dejong","year":"2015","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.vaccine.2021.12.050_b0105","doi-asserted-by":"crossref","first-page":"6e1","DOI":"10.1016\/j.jpeds.2013.06.021","article-title":"Tetanus, diphtheria, acellular pertussis vaccine during pregnancy: pregnancy and infant health outcomes","volume":"163","author":"Shakib","year":"2013","journal-title":"J Pediatr"},{"key":"10.1016\/j.vaccine.2021.12.050_b0110","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1002\/bdr2.23622","article-title":"Major birth defects after vaccination reported to the Vaccine Adverse Event Reporting System (VAERS), 1990 to 2014","volume":"109","author":"Moro","year":"2017","journal-title":"Birth Defects Res"},{"issue":"9191","key":"10.1016\/j.vaccine.2021.12.050_b0115","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/S0140-6736(99)04411-6","article-title":"Reporting bias in retrospective ascertainment of drug-induced embryopathy","volume":"354","author":"Bar-Oz","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2021.12.050_b0120","unstructured":"Food and Drug Administration - US Department of Health and Human Services - Center for Drug Evaluation and Research - Center for Biologics Evaluation and Research 2002. Guidance for industry: establishing pregnancy exposure registries. Available from https:\/\/www.fda.gov\/media\/75607\/download [last accessed 18 March 2020]."},{"key":"10.1016\/j.vaccine.2021.12.050_b0125","unstructured":"European Medicines Agency - Committee for Medicinal Products for Human Use 2005. Guideline on the exposure to medicinal products during pregnancy: Need for post-authorisation data. Available from https:\/\/www.ema.europa.eu\/en\/documents\/regulatory-procedural-guideline\/guideline-exposure-medicinal-products-during-pregnancy-need-post-authorisation-data_en.pdf [last accessed 28 November 2020]."},{"key":"10.1016\/j.vaccine.2021.12.050_b0130","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/bdra.10111","article-title":"The Metropolitan Atlanta Congenital Defects Program: 35 years of birth defects surveillance at the Centers for Disease Control and Prevention","volume":"67","author":"Correa-Villase\u00f1or","year":"2003","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"10.1016\/j.vaccine.2021.12.050_b0135","unstructured":"Food and Drug Administration 2018. FDA biefing document: Risk communication advisory committee meeting March 5-6, 2018. Communicating information about risks in pregnancy in product labelling for patients and providers to make informed decisions about the use of drugs during pregnancy. Available from https:\/\/www.fda.gov\/media\/110905\/download [last accessed 18 March 2020]."},{"key":"10.1016\/j.vaccine.2021.12.050_b0140","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0022-3476(87)80543-7","article-title":"Predictive value of minor anomalies. I. Association with major malformations","volume":"110","author":"Leppig","year":"1987","journal-title":"J Pediatr"},{"key":"10.1016\/j.vaccine.2021.12.050_b0145","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.pedneo.2014.10.002","article-title":"Birth defects in the newborn population: race and ethnicity","volume":"56","author":"Egbe","year":"2015","journal-title":"Pediatr Neonatol"},{"key":"10.1016\/j.vaccine.2021.12.050_b0150","first-page":"1","article-title":"Update on overall prevalence of major birth defects\u2013Atlanta, Georgia, 1978\u20132005","volume":"57","author":"Centers for Disease Control and Prevention","year":"2008","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2021.12.050_b0155","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s40121-019-00265-6","article-title":"Safety of maternal immunization against pertussis: A systematic review","volume":"8","author":"D\u2019Heilly","year":"2019","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.vaccine.2021.12.050_b0160","doi-asserted-by":"crossref","first-page":"F456","DOI":"10.1136\/archdischild-2016-312341","article-title":"Maternal vaccination against pertussis: a systematic review of the recent literature","volume":"102","author":"Gkentzi","year":"2017","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"10.1016\/j.vaccine.2021.12.050_b0165","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1093\/cid\/ciy244","article-title":"A randomized controlled trial of the safety and immunogenicity of tetanus, diphtheria, and acellular pertussis vaccine immunization during pregnancy and subsequent infant immune response","volume":"67","author":"Halperin","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2021.12.050_b0170","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1001\/jama.2014.14825","article-title":"Evaluation of the association of maternal pertussis vaccination with obstetric events and birth outcomes","volume":"312","author":"Kharbanda","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2021.12.050_b0175","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1097\/AOG.0000000000001888","article-title":"Safety of tetanus, diphtheria, and pertussis vaccination during pregnancy: A systematic review","volume":"129","author":"McMillan","year":"2017","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.vaccine.2021.12.050_b0180","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3390\/vaccines7040147","article-title":"A retrospective cohort study of safety outcomes in New Zealand infants exposed to Tdap vaccine in utero","volume":"7","author":"Petousis-Harris","year":"2019","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2021.12.050_b0185","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1080\/21645515.2019.1627161","article-title":"Safety of reduced antigen content diphtheria-tetanus-acellular pertussis vaccine when administered during pregnancy as part of the maternal immunization program in Brazil: a single center, observational, retrospective, cohort study","volume":"15","author":"Sancovski","year":"2019","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2021.12.050_b0190","doi-asserted-by":"crossref","first-page":"e20173310","DOI":"10.1542\/peds.2017-3310","article-title":"Infant hospitalizations and mortality after maternal vaccination","volume":"141","author":"Sukumaran","year":"2018","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2021.12.050_b0195","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/j.vaccine.2018.01.059","article-title":"Assessing the reactogenicity of Tdap vaccine administered during pregnancy and antibodies to Bordetella pertussis antigens in maternal and cord sera of Thai women","volume":"36","author":"Wanlapakorn","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.12.050_b0200","doi-asserted-by":"crossref","first-page":"5173","DOI":"10.1016\/j.vaccine.2018.07.011","article-title":"Pertussis Immunisation in Pregnancy Safety (PIPS) Study: A retrospective cohort study of safety outcomes in pregnant women vaccinated with Tdap vaccine","volume":"36","author":"Griffin","year":"2018","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21016583?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21016583?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:09:06Z","timestamp":1759403346000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X21016583"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S0264410X21016583"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.12.050","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fourteen years of the Pregnancy Registry on maternal immunisation with a reduced-antigen-content tetanus-diphtheria-acellular pertussis (Tdap) vaccine","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.12.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 GlaxoSmithKline Biologicals S.A. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}